[logo] HealthTree Foundation
search person

What Is T-Cell Prolymphocytic Leukemia?

T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive type of mature T-cell leukemia. It is characterized by the proliferation of small to medium-sized prolymphocytes (a type of white blood cell) with a mature T-cell phenotype (observable individual traits). T-PLL typically presents in older adults and is more common in men than in women. The disease is often aggressive, with rapid progression and resistance to chemotherapy. Patients with T-PLL often present with: generalized lymphadenopathy (swollen lymph nodes), hepatosplenomegaly (swelling of the liver or spleen), skin lesions, and marked by a high white blood cell count.

Why do people get T-Cell Prolymphocytic Leukemia?

The exact cause of T-cell prolymphocytic leukemia is not known. However, it is believed to be related to genetic mutations. The most common genetic abnormality in T-PLL is the inversion or translocation of chromosome 14, which leads to the overexpression of the TCL1 gene. This gene plays a role in the development and function of T-cells, and its overexpression may contribute to the development of T-PLL. T-cells are a type of white blood cell called lymphocytes. They help your immune system fight germs and protect you from disease.

Other factors that may contribute to the development of T-PLL include exposure to certain chemicals or radiation, a history of other blood disorders, and a weakened immune system. However, in many cases, the cause of T-PLL is not known. It is also important to note that T-PLL is not contagious and cannot be passed from person to person.

Who gets T-Cell Prolymphocytic Leukemia?

T-PLL is a rare T cell leukemia. The disease accounts for approximately 2% of cases of mature lymphocytic leukemia in adults. The pathology is common in elderly patients (older than 65 yrs) with an age range of 30 to 94 years. There is a slight male predominance with a male to female ratio of 1.33. Mutations of the ATM (ataxia-telangiectasia mutation) gene on 11q23 occur in 80% to 90% of the T-PLL population

Want to Learn More About T-Cell Prolymphocytic Leukemia?

Keep reading HealthTree for T-Cell Prolymphocytic Leukemia's 101 pages!

T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive type of mature T-cell leukemia. It is characterized by the proliferation of small to medium-sized prolymphocytes (a type of white blood cell) with a mature T-cell phenotype (observable individual traits). T-PLL typically presents in older adults and is more common in men than in women. The disease is often aggressive, with rapid progression and resistance to chemotherapy. Patients with T-PLL often present with: generalized lymphadenopathy (swollen lymph nodes), hepatosplenomegaly (swelling of the liver or spleen), skin lesions, and marked by a high white blood cell count.

Why do people get T-Cell Prolymphocytic Leukemia?

The exact cause of T-cell prolymphocytic leukemia is not known. However, it is believed to be related to genetic mutations. The most common genetic abnormality in T-PLL is the inversion or translocation of chromosome 14, which leads to the overexpression of the TCL1 gene. This gene plays a role in the development and function of T-cells, and its overexpression may contribute to the development of T-PLL. T-cells are a type of white blood cell called lymphocytes. They help your immune system fight germs and protect you from disease.

Other factors that may contribute to the development of T-PLL include exposure to certain chemicals or radiation, a history of other blood disorders, and a weakened immune system. However, in many cases, the cause of T-PLL is not known. It is also important to note that T-PLL is not contagious and cannot be passed from person to person.

Who gets T-Cell Prolymphocytic Leukemia?

T-PLL is a rare T cell leukemia. The disease accounts for approximately 2% of cases of mature lymphocytic leukemia in adults. The pathology is common in elderly patients (older than 65 yrs) with an age range of 30 to 94 years. There is a slight male predominance with a male to female ratio of 1.33. Mutations of the ATM (ataxia-telangiectasia mutation) gene on 11q23 occur in 80% to 90% of the T-PLL population

Want to Learn More About T-Cell Prolymphocytic Leukemia?

Keep reading HealthTree for T-Cell Prolymphocytic Leukemia's 101 pages!

newsletter icon

Get the latest thought leadership on your T-Cell Prolymphocytic Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for T-Cell Prolymphocytic Leukemia Sponsors:

Abbvie
Genentech